Sabby Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,146
Closed -$2.8M 330
2016
Q2
$2.8M Buy
1,146
+123
+12% +$3.49K 0.15% 86
2016
Q1
$3.44M Buy
1,023
+888
+658% +$28K 0.17% 61
2015
Q4
$404K Hold
135
0.02% 251
2015
Q3
$426K Buy
135
+44
+48% +$2.15K 0.02% 307
2015
Q2
$439K Sell
91
-3
-3% -$126 0.02% 265
2015
Q1
$408K Sell
94
-939
-91% -$33.7K 0.02% 245
2014
Q4
$2.72K Sell
1,033
-13
-1% -$285 0.09% 104
2014
Q3
$1.86K Buy
+1,046
New +$21.4K 0.07% 116

Other funds holding PGEN

Sabby Management's PGEN Position: Q3 2016 in Review

Sabby Management sold out of Precigen (PGEN) in Q3 2016, closing a stake of 121,442 shares — an estimated $2.96M sold.

Sabby Management first reported a position in PGEN in Q3 2014 and held it in 4 quarters. The position peaked at $3.79M in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

  • Sabby Management reported no remaining Precigen position as of Q3 2016 after selling out during the quarter.
  • Sabby Management sold 121,442 Precigen shares in Q3 2016, an estimated $2.96M.
  • Sabby Management first reported a position in Precigen in Q3 2014 and held it in 4 quarters.
  • Sabby Management's Precigen position peaked at $3.79M in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.